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Potassium phosphate (monobasic and dibasic) and benzphetamine were 
purchased from Sigma-Aldrich (St. Louis, MO). 1,2-dimyristoyl-sn-glycero-3-
phosphocholine (DMPC) was purchased from Avanti Polar Lipids, Inc. 
(Alabaster, AL). Deuterium oxide (D2O) and 15N Celtone Base Powder were 
purchased from Cambridge Isotope Laboratories (Tewksbury, MA). The 5-mm 
symmetrical D2O-matched Shigemi NMR microtubes were purchased from 
Shigemi, Inc (Allison Park, PA). 
Methods 
Expression and purification of proteins. FBD of rat CPR was purified as 
described previously [1]. The fl-FBD gene is encoded on a pSC plasmid, and is 
preceeded by the OmpA signal peptide [2]. Briefly, fl-FBD was expressed in E. 
coli C41 cells in either LB medium for unlabeled protein, or M9 medium for U-
15N or U-15N/13C labeled samples, supplemented with 5 nM FMN. Protein 
expression was induced at OD600 = 0.7 by adding 0.4 mM IPTG to the 
cultures for 16 h at 30 °C. After cell harvest at 6000 x g and 4 °C, the cells 
were lysed by 30 µg/ml lysozyme and protease inhibitor in Tris-Acetate buffer 
pH 7.4 for 30 mins at 4 °C, followed by sonication (with 1 s on and 1 s off 
pulses) for 5 mins. The membrane fraction was pelleted by ultracentrifugation 
at 105,000 x g and 4 °C for 45 mins, and further treated with 0.3% (v/v) Triton 
X-100 for 16 h at 4 °C. The solubilized membrane proteins were purified by 
DEAE anion exchange chromatography twice. For this purpose, the protein 
was loaded onto the column and eluted using a NaCl gradient ranging from 
0.2 M to 0.5 M in Tris-Acetate pH 7.4 containing 1 µM FMN, 0.3% (v/v) 
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sodium cholate. Full-length CYP2B4 was expressed and purified as described 
in the literature [3]. 
 
Reconstitution of full-length proteins in nanodiscs. Empty nanodiscs were 
produced from the 4F peptide and DMPC in 40 mM sodium phosphate pH 
7.4. The 4F peptide was predissolved to a stock concentration of 10 mg/ml. 
DMPC was predissolved to 20 mg/ml and vortexed and sonicated to achieve 
a homogeneous suspension. The 4F peptide and DMPC were mixed at a 
1:1.5 (w/w) ratio, and incubated for 16 h at 37 °C with gentle agitation. The 
nanodiscs were purified by size exclusion chromatography (SEC) using a 
Superdex 200 Increase 300/10 GL column operated on an ÄKTA purifier (GE 
Healthcare, Freiburg, Germany), and incubated with fl-FBD or fl-CYP2B4 at 
molar ratios of 1:1.2 (protein/nanodisc), and incubated for 16 h at 25 °C with 
gentle agitation. The reconstitution was further purified by SEC. Fractions 
showing absorbance at 412 nm (CYP2B4) or 454 nm (FBD) were pooled and 
used for further analysis. In order to form a complex, fl-FBD was added to 
purified CYP2B4 reconstituted in nanodiscs at a molar ratio of 1:1. The empty 
nanodiscs, proteins, and reconstituted proteins were subjected to dynamic 
light scattering (DLS) measurements on a DynaPro NanoStar instrument 
(Wyatt Technology Corp., Santa Barbara, USA) at 25 °C for 10 acquisitions of 
5 s each. DLS and SEC measurements confirm the increase of the 
hydrodynamic radius after stepwise incubation with fl-CYP2B4 and fl-FBD. 
The relative ratio of SEC purified reconstituted protein complex in nanodiscs 
was calculated using the absorbance at 417 nm and 454 nm for CYP2B4 and 
FBD, respectively (Figure S5). 
	 4	
SAXS measurements. SAXS data were acquired at the BioCAT beamline at 
Sector 18-ID of the APS in Argonne National Laboratory, Chicago. Both 
empty nanodiscs and redox complex fl-CYP2B4-FBD anchored in 4F-DMPC 
nanodiscs were prepared (as mentioned above) at 60 µM and ~20 µM, 
respectively, in 1 ml in buffer containing 40 mM potassium phosphate, pH 7.4. 
Both nanodiscs and reconstituted protein complex purified from size exclusion 
chromatography (SEC) were delivered using an autosampler with continuous 
unidirectional flow and recorded with 1 s exposure. Data was acquired as 
previously described elsewhere [4]. Scattering intensity plots (Figure 2c) are 
the average of triplicate experiments and subtracted with buffer. SAXS data 
was processed using the program PRIMUS in ATSAS package [5]. The 
scattering curves were first analyzed for aggregation using the Guinier region. 
The forward scattering I(0) and the radius of gyration, Rg, were computed 
using the Guinier approximation. Rg provides a measure of the overall size of 
the macromolecule (Figure S4a). The pair distance distribution function P(r), 
was computed from the extended scattering patterns using the indirect 
transform program GNOM in PRIMUS. The maximum dimension of the 
particle, Dmax, estimated from the P(r) function satisfying the condition P(r)=0 
(Figure S4c-d). The molecular folding and compactness of reconstituted full-
length redox complex in nanodisc were analyzed by using the normalized 
Kratky plot (Figure S4f). Bell-shaped profile from scattering pattern in a 
normalized Kratky plot demonstrates the folded protein. Ab initio shape 
reconstruction of nanodiscs and redox complex (fl-CYP2B4-fl-FBD) anchored 
in nanodiscs was obtained by DAMMIN/DAMMIF module in PRIMUS from 
ATSAS package (Figures 2d and S4e). 
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NMR experiments. All NMR experiments were carried out at 298 K (25 °C). 
3D HNCA, HNCACB and CBCA(CO)NH [6-10] experiments were performed on 
a Bruker 900 MHz NMR spectrometer equipped with a triple-resonance 
cryoprobe (1H, 15N, 13C) on a sample containing 250 µM protein and 10% 
D2O. All other NMR experiments were carried out on a Bruker Avance II 600 
MHz equipped with a triple-resonance cryoprobe (1H, 15N, 13C) at FBD 
concentrations of 100 µM. 2D 1H-15N TROSY HSQC [11, 12] spectra were 
recorded with 256 t1 increments.  
Sequential assignment and analysis of CPSs, signal intensities was 
performed using CcpNmr Analysis 2.4.1 [13]. Secondary structural elements 
were predicted using TALOS+ [14] and random coil values as reported by 
Wishart et al [15]. Chemical shift perturbations (CSP) were calculated from 1H-
15N TROSY HSQCs using the following equation: 
 
To record solvent PRE (sPRE) data, 1 mM of the lanthanide [Gd(DTPA-BMA)] 
[16] was added to the sample and measured immediately. Residues of fl-FBD 
in the binding interface to fl-CYP2B4 will be protected from the sPRE singal 
quenching upon complex formation. This extend (ΔQuenching) was 
determined by the following equation: 
ΔQuenching = (complexsPRE/complexref)-(fl-FBDsPRE/fl-FBDref) 
 
Structural model calculation. A structural model for the globular domain of 
FBD was calculated using the Chemical-Shift-ROSETTA (CS-ROSETTA) 
server from the Biological Magnetic Resonance Data Bank.[17-20] CS-
ROSETTA is a robust tool for de novo protein structure generation, using 13C, 
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15N and 1H NMR chemical shifts as input. It employs SPARTA-based 
selection of protein fragments from the PDB, in conjunction with a regular 
ROSETTA Monte Carlo assembly and relaxation procedure, to generate 
structures of minimized energies. 
 
CYPP450-FBD complex structure calculation. HADDOCK 2.2 webserver 
[21] was used to dock FBD and CYP450 based on a number of ambiguous 
restraints derived from NMR and site-directed mutagenesis experiments [22] 
(Table 1). It involves rigid-body docking, followed by molecular dynamics 
simulations that allow selected amino acid side chains, as well as parts of the 
backbone, to move freely to improve the complementarity and electrostatic 
interactions at the interface. For this calculation, we used the X-ray structure 
of rat FBD (PDB structure: 1AMO [23]; Val64 to Ala-235 and the heme domain 
of CYP2B4 (PDB code 1SUO [24]). Docking was performed using default 
parameters in the absence of a membrane environment. However, it must be 
noted that all NMR, SAXS and catalytic data were acquired on membrane 
anchored full-length proteins. Ligand topology and parameter files were 
generated from the PRODRG2 server [25]. NMR based CSPs and differential 
line broadening data were used as proximity restraints to guide the docking 
process whereby rigid body docking follows the semi-flexible refinement and 
energy minimization in explicit solvent to allow the free movement of 
backbone and side chain atoms of the selected amino acids to improve the 
intermolecular packing at protein interface. The active ambiguous restraints 
were chosen based on literature for CYP2B4 [22] and experimentally 
determined NMR restraints for FBD. Rigid body energy minimization was 
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used for docking 1000 structures of the complex. The second step included 
semi-rigid simulated annealing from which the best 200 structures were 
selected for refinement. The best 200 structures were further refined with 
explicit solvent in an 8.0 Å shell of TIP3P water molecules. Models are 
displayed using PyMOL [26]. 
 
Stopped-flow measurement of electron transfer from hydroquinone FMN 
to oxyferrous fl-CYP2B4 reconstituted in 4F-peptide based lipid 
nanodiscs. All experiments were performed at 15 °C under anaerobic 
conditions using a Hi-Tech stopped-flow apparatus in a glove box 
([O2]<<2ppm). All stock solutions (proteins and benzphetamine) were 
prepared in degassed and air saturated 40 mM potassium phosphate buffer 
pH 7.4. Degassed and air saturated buffers were prepared by purging 
nitrogen and air, respectively for 30 minutes. Stock solutions of 
benzphetamine and protein were prepared at 1 mM and 3.5 mM, respectively 
in 40 mM potassium phosphate buffer pH 7.4. An equimolar amount of full-
length proteins (CYP2B4 and FBD) in the nanodiscs was incubated overnight 
at 4°C in the glove box. After the addition of benzphetamine to the protein 
complex, the protein was stoichiometrically reduced with dithionite. The 
stoichiometric reduction of the protein complex yielded ferrous CYP450, and 
the 2-electron reduced FBD (FMNH2) The 3-electron-reduced protein complex 
was loaded into the stopped-flow spectrophotometer and mixed with air-
saturated potassium phosphate buffer buffer. Intermolecular electron transfer 
from FBD and to oxyferrous CYP450 was observed as oxidation of FBD at 
585 nm. 
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Evolutionary conservation analysis. The ConSurf web server 
(http://consurf.tau.ac.il/2016/)[27-31] uses a query sequence or structure and 
analyzes the evolutionary pattern of the amino acids to reveal the regions 






Figure S1: (a) SDS-PAGE of tr-FBD (21 kDa) and fl-FBD (28 kDa). (b) ESI 






Figure S2: (a) Representative strips selected from 3D HNCACB spectra of tr-
FBD in solution (black) and fl-FBD in nanodiscs (red). Peaks originating from 
Cα and Cβ resonances are indicated in blue and green, respectively. (b) Upper 
panel: Secondary structural elements as predicted by TALOS+ [14]. Lower 
panel: Prediction of the transmembrane sequence based on TMHMM, a 
membrane protein topology prediction server [32]. The indicated secondary 
structural elements are highly comparable to those reported in the crystal 




Figure S3: (a) An ensemble of 10 lowest energy structural models determined 
using CS-ROSETTA showing the well-conserved Rossman fold. Right, 
Superimposed X-ray (cyan) and NMR (red) structures with r.m.s.d. values of 
~3.0 Å. (b) Ramachandran plot generated by PROCHECK [34, 35] validation 
software showing the stereochemical quality of CS-ROSETTA [19] derived 






Figure S4: SAXS measurements and analysis of the fl-FBD fl-CYP2B4 
complex in peptide-based nanodiscs. (a-b) SAXS curves in reciprocal 
(Fourier) space with linear Guinier region (inserts) demonstrate sample 
uniformity. Radii of gyration (Rg) calculated from Guinier plot of nanodiscs and 
reconstituted full-length redox complex (fl-FBD-fl-CYP2B4) are 44.95±0.79 
and 67.98±1.52 Å, respectively. (c-d) Pair-distance distribution function 
(PDDF) of empty nanodiscs and the reconstituted redox complex obtained 
using indirect Fourier transform in GNOM module from ATSAS package. The 
region of negative contrast in empty nanodiscs is a characteristic property of 
hydrophobic acyl chains in lipid bilayers. This effect is present in both cases, 
however it is more pronounced in empty nanodiscs, as the relative 
concentration of acyl chains is higher. (e) Schematic representation of 
peptide-based nanodiscs (left) and overlapped ab initio model of peptide-
based nanodisc (green) generated from SAXS data using the 
DAMMIN/DAMMIF module in Primus (right). (f) Normalized Kratky plot reveals 
a bell-shaped profile for the fl-FBD-fl-CYP2B4 complex reconstituted in 
nanodiscs. This experimental result further confirms the reconstitution of a 
properly folded protein-protein complex in peptide-based lipid nanodiscs. All 
SAXS data were analyzed using various modules of the ATSAS package [5].	
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Figure S5: UV-Vis spectra for SEC purified nanodisc embedded CYP2B4 
(red), FBD (yellow) and CYP2B4-FBD complex (orange). The absorption 
maxima at 417 nm and a/b bands at 530-585 nm are signature features of 
CYP2B4. However, FBD shows a broad band from 405-520 nm with 
absorption maxima at 454 nm. The presence of both full-length proteins 
(CYP2B4-FBD) in the nanodisc can be confirmed by the broad peak at ~ 450 
nm (marked by an arrow) along with a peak at 417 nm and a/b bands at 530-
585 nm. Based on the absorbance of the respective proteins in the complex 
(CYP2B4-FBD), the relative ratio of CYP2B4 to FBD was observed to be 0.95, 
indicative of 1:1 protein:protein ratio in the complex.	
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Figure S6: Stopped-flow data for electron transfer from fl-FBD to fl-CYP2B4. 
The proteins were incubated individually (yellow and red for FBD and 
CYP2B4, respectively), in complex (orange) with nanodiscs and the 

























Figure S7: (a) Representative excerpts displaying CSPs experienced by Y117 
and H180 of fl-FBD in nanodiscs without (black) and with fl-CYP2B4 (blue). 
(b) Representative 1H-1D slices extracted from 1H-15N-TROSY-HSQC 
demonstrate attenuation of Q194 and preservation of E239 resonances from 
fl-FBD in nanodiscs without (black) and with fl-CYP2B4 (blue). (c) Schematic 
illustration of sPRE experimental setup; Gd (DTPA-BMA) (yellow) was added 




Figure S8: ConSurf analysis [30, 31] of fl-CYP2B4 based on the structural and 
functional importance of residues reveals conserved (purple-9) and variable 
residues (blue-1) present on proximal and distal sides of CYP450, 
respectively. R125 (ball and stick), located in the C-helix on the proximal side 
of fl-CYP2B4 is one of the most conserved residues and found to be important 
for electron transfer to heme. 
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Table 1: List of restraints used in HADDOCK simulations [21] for the full-length 
complex in nanodiscs. Active restraints on FBD site were obtained from 
TROSY based 15N-HSQC experiments on full-length complex reconstituted in 
lipid nanodiscs, whereas site directed mutagenesis data [22] was used for 
CYP2B4. 
 
 fl-FBD fl-CYP2B4 
Ambiguous 
active restraints 88, 116, 143, 146, 175, 177, 179 





Table 2: Energy statistics of the lowest energy cluster of the FBD-CYP2B4 
complex obtained using HADDOCK server [21]. 
 
HADDOCK score -106.0 +/- 6.0 
RMSD from the overall lowest-energy structure  0.8 +/- 0.5 
Van der Waals energy -47.5 +/- 6.7 
Electrostatic energy -489.6 +/- 22.5 
Desolvation energy 38.2 +/- 6.2 
Restraints violation energy 10.7 +/- 16.27 
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